Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: Insights into genotype-phenotype correlation

International Journal of Endocrinology

Volumn 2012, Issue , 2012, Pages

  Capalbo, Donatella ^a   De Martino, Lucia ^a   Giardino, Giuliana ^a   Di Mase, Raffaella ^a   Di Donato, Iolanda ^a   Parenti, Giancarlo ^a   Vajro, Pietro ^b   Pignata, Claudio ^a   Salerno, Mariacarolina ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; AUTOIMMUNE REGULATOR PROTEIN; INTERFERON; INTERLEUKIN 17F; INTERLEUKIN 22; NEUTRALIZING ANTIBODY;

ADDISON DISEASE; ADRENAL CORTEX INSUFFICIENCY; ADRENAL INSUFFICIENCY; ANTIBODY SPECIFICITY; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CD4+ CD25+ T LYMPHOCYTE; DISEASE SEVERITY; ENDOCRINE DISEASE; EXON; GASTROINTESTINAL DISEASE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; HYPOCALCEMIA; HYPOPARATHYROIDISM; LIFE EXPECTANCY; MUCOCUTANEOUS CANDIDIASIS; ONSET AGE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVIEW;

EID: 84869025433     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2012/353250     Document Type: Review

References (85)

1. Finnish-German APECED Consortium, An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nature Genetics 1997 17 4 399 403 2-s2.0-0346599403
2. Mathis D., Benoist C., Aire. Annual Review of Immunology 2009 27 287 312 2-s2.0-67549118180 10.1146/annurev.immunol.25.022106.141532
3. Husebye E. S., Gebre-Medhin G., Tuomi T., Perheentupa J., Landin-Olsson M., Gustafsson J., Rorsman F., Kämpe O., Autoantibodies against, aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I. The Journal of Clinical Endocrinology and Metabolism 1997 82 1 147 150 2-s2.0-0031033052 10.1210/jc.82.1.147 (Pubitemid 27021286)
4. Söderbergh A., Myhre A. G., Ekwall O., Gebre-Medhin G., Hedstrand H., Landgren E., Miettinen A., Eskelin P., Halonen M., Tuomi T., Gustafsson J., Husebye E. S., Perheentupa J., Gylling M., Manns M. P., Rorsman F., Kämpe O., Nilsson T., Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. The Journal of Clinical Endocrinology and Metabolism 2004 89 2 557 562 2-s2.0-10744233772 10.1210/jc.2003-030279 (Pubitemid 38269857)
5. Ahonen P., Myllarniemi S., Sipila I., Perheentupa J., Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. The New England Journal of Medicine 1990 322 26 1829 1836 2-s2.0-0025295238 (Pubitemid 20200407)
6. Zlotogora J., Shapiro M. S., Polyglandular autoimmune syndrome type I among Iranian Jews. Journal of Medical Genetics 1992 29 11 824 826 2-s2.0-0026481974
7. Perheentupa J., Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. The Journal of Clinical Endocrinology and Metabolism 2006 91 8 2843 2850 2-s2.0-33747662305 10.1210/jc.2005-2611 (Pubitemid 44271722)
8. Rautemaa R., Hietanen J., Niissalo S., Pirinen S., Perheentupa J., Oral and oesophageal squamous cell carcinomaa complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I). Oral Oncology 2007 43 6 607 613 2-s2.0-34249805682 10.1016/j.oraloncology.2006.07.005 (Pubitemid 46856270)
9. Kisand K., Boe Wolff A. S., Podkrajšek K. T., Tserel L., Link M., Kisand K. V., Ersvaer E., Perheentupa J., Erichsen M. M., Bratanic N., Meloni A., Cetani F., Perniola R., Ergun-Longmire B., Maclaren N., Krohn K. J. E., Pura M., Schalke B., Ströbel P., Leite M. I., Battelino T., Husebye E. S., Peterson P., Willcox N., Meager A., Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. The Journal of Experimental Medicine 2010 207 2 299 308 2-s2.0-77149147477 10.1084/jem.20091669
10. Brown E. M., Vassilev P. M., Hebert S. C., Calcium ions as extracellular messengers. Cell 1995 83 5 679 682 2-s2.0-0028820577
11. Li Y., Song Y. H., Rais N., Connor E., Schatz D., Muir A., Maclaren N., Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. The Journal of Clinical Investigation 1996 97 4 910 914 2-s2.0-0030051024 (Pubitemid 26070569)
12. Gylling M., Kääriäinen E., Väisänen R., Kerosuo L., Solin M. L., Halme L., Saari S., Halonen M., Kämpe O., Perheentupa J., Miettinen A., The hypoparathyroidism of autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy protective effect of male sex. The Journal of Clinical Endocrinology and Metabolism 2003 88 10 4602 4608 2-s2.0-10744230766 10.1210/jc.2003-030700 (Pubitemid 37357500)
13. Gavalas N. G., Kemp E. H., Krohn K. J. E., Brown E. M., Watson P. F., Weetman A. P., The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1. The Journal of Clinical Endocrinology and Metabolism 2007 92 6 2107 2114 2-s2.0-34347271707 10.1210/jc.2006-2466 (Pubitemid 46997107)
14. Alimohammadi M., Björklund P., Hallgren A., Pöntynen N., Szinnai G., Shikama N., Keller M. P., Ekwall O., Kinkel S. A., Husebye E. S., Gustafsson J., Rorsman F., Peltonen L., Betterle C., Perheentupa J., Åkerström G., Westin G., Scott H. S., Holländer G. A., Kämpe O., Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. The New England Journal of Medicine 2008 358 10 1018 1028 2-s2.0-40449109084 10.1056/NEJMoa0706487 (Pubitemid 351347101)
15. Tomar N., Kaushal E., Das M., Prevalence and significance of NALP5 autoantibodies in patients with idiopathic hypoparathyroidism. The Journal of Clinical Endocrinology and Metabolism 2012 97 4 1219 1226
16. Betterle C., Dal Pra C., Mantero F., Zanchetta R., Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocrine Reviews 2002 23 3 327 364 2-s2.0-0035985317 10.1210/er.23.3.327 (Pubitemid 34651950)
17. Husebye E. S., Perheentupa J., Rautemaa R., Kämpe O., Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type i. Journal of Internal Medicine 2009 265 5 514 529 2-s2.0-64249161198 10.1111/j.1365-2796.2009.02090.x
18. Merenmies L., Tarkkanen A., Chronic bilateral keratitis in autoimmune polyendocrinopathy-candidiadis-ectodermal dystrophy (APECED). Acta Ophthalmologica Scandinavica 2000 78 5 532 535 2-s2.0-0033833151 10.1034/j.1600-0420.2000.078005532.x
19. Clemente M. G., Obermayer-Straub P., Meloni A., Strassburg C. P., Arangino V., Tukey R. H., De Virgiliis S., Manns M. P., Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1. The Journal of Clinical Endocrinology and Metabolism 1997 82 5 1353 1361 2-s2.0-0030919380 (Pubitemid 27200400)
20. Gebre-Medhin G., Husebye E. S., Gustafsson J., Winqvist O., Goksoyr A., Rorsman F., Kämpe O., Cytochrome P450IA2 and aromatic L-amino acid decarboxylase are hepatic autoantigens in autoimmune polyendocrine syndrome type I. FEBS Letters 1997 412 3 439 445 2-s2.0-0030837075 10.1016/S0014-5793(97) 00797-7 (Pubitemid 27337086)
21. Clemente M. G., Meloni A., Obermayer-Straub P., Frau F., Manns M. P., De Virgiliis S., Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1. Gastroenterology 1998 114 2 324 328 2-s2.0-0031890201 10.1016/S0016-5085(98)70484-6 (Pubitemid 28093540)
22. Gianani R., Eisenbarth G. S., Autoimmunity to gastrointestinal endocrine cells in autoimmune polyendocrine syndrome type i. The Journal of Clinical Endocrinology and Metabolism 2003 88 4 1442 1444 2-s2.0-0038100211 10.1210/jc.2003-030247 (Pubitemid 36623352)
23. Ekwall O., Hedstrand H., Grimelius L., Haavik J., Perheentupa J., Gustafsson J., Husebye E., Kämpe O., Rorsman F., Identification of tryptophan hydroxylase as an intestinal autoantigen. The Lancet 1998 352 9124 279 283 2-s2.0-0032566209 10.1016/S0140-6736(97)11050-9 (Pubitemid 28340146)
24. Friedman T. C., Thomas P. M., Fleisher T. A., Feuillan P., Parker R. I., Cassorla F., Chrousos G. P., Frequent occurrence of asplenism and cholelithiasis in patients with autoimmune polyglandular disease type I. American Journal of Medicine 1991 91 6 625 630 2-s2.0-0026334341 10.1016/0002-9343(91)90215-J
25. Orlova E. M., Bukina A. M., Kuznetsova E. S., Kareva M. A., Zakharova E. U., Peterkova V. A., Dedov I. I., Autoimmune polyglandular syndrome type 1 in Russian patients: clinical variants and autoimmune regulator mutations. Hormone Research in Paediatrics 2010 73 6 449 457 2-s2.0-77952310454 10.1159/000313585
26. Betterle C., Greggio N. A., Volpato M., Clinical review 93: autoimmune polyglandular syndrome type 1. The Journal of Clinical Endocrinology and Metabolism 1998 83 4 1049 1055 2-s2.0-0031733489 10.1210/jc.83.4.1049 (Pubitemid 28496366)
27. Alimohammadi M., Dubois N., Sköldberg F., Hallgren Å.., Tardivel I., Hedstrand H., Haavik J., Husebye E. S., Gustafsson J., Rorsman F., Meloni A., Janson C., Vialettes B., Kajosaari M., Egner W., Sargur R., Pontén F., Amoura Z., Grimfeld A., De Luca F., Betterle C., Perheentupa J., Kämpe O., Carel J. C., Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen. Proceedings of the National Academy of Sciences of the United States of America 2009 106 11 4396 4401 2-s2.0-63149126091 10.1073/pnas.0809986106
28. Al-Owain M., Kaya N., Al-Zaidan H., Al-Muhsen S., Bin Hussain I., Al-Manea H., Al H., Kennedy S., Iqbal M. A., Al-Mojalli H., Al-Bakheet A., Puel A., Casanova J. L., Renal failure associated with APECED and terminal 4q deletion: Evidence of autoimmune nephropathy. Clinical and Developmental Immunology 2010 2010 7 2-s2.0-79251578613 10.1155/2010/586342 586342
29. Ulinski T., Perrin L., Morris M., Houang M., Cabrol S., Grapin C., Chabbert-Buffet N., Bensman A., Deschênes G., Giurgea I., Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome with renal failure: impact of posttransplant immunosuppression on disease activity. The Journal of Clinical Endocrinology and Metabolism 2006 91 1 192 195 2-s2.0-30344444284 10.1210/jc.2005-1538 (Pubitemid 43069137)
30. Di Sabatino A., Carsetti R., Corazza G. R., Post-splenectomy and hyposplenic states. The Lancet 2011 378 9785 86 97 2-s2.0-79959971539 10.1016/S0140-6736(10)61493-6
31. Watanabe M., Ochi H., Arahata H., Myopathy in autoimmune polyendocrinopathycandidiasis-ectodermal dystrophy. Muscle Nerve 2012 45 6 904 908
32. Mazza C., Buzi F., Ortolani F., Vitali A., Notarangelo L. D., Weber G., Bacchetta R., Soresina A., Lougaris V., Greggio N. A., Taddio A., Pasic S., de Vroede M., Pac M., Kilic S. S., Ozden S., Rusconi R., Martino S., Capalbo D., Salerno M., Pignata C., Radetti G., Maggiore G., Plebani A., Notarangelo L. D., Badolato R., Clinical heterogeneity and diagnostic delay of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. Clinical Immunology 2011 139 1 6 11 2-s2.0-79953025343 10.1016/j.clim.2010.12.021
33. Capalbo D., Elefante A., Spagnuolo M. I., Mazza C., Betterle C., Pignata C., Salerno M., Posterior reversible encephalopathy syndrome in a child during an accelerated phase of a severe APECED phenotype due to an uncommon mutation of AIRE. Clinical Endocrinology 2008 69 3 511 513 2-s2.0-49649114637 10.1111/j.1365-2265.2008.03206.x
34. DeVoss J. J., Shum A. K., Johannes K. P. A., Lu W., Krawisz A. K., Wang P., Yang T., LeClair N. P., Austin C., Strauss E. C., Anderson M. S., Effector mechanisms of the autoimmune syndrome in the murine model of autoimmune polyglandular syndrome type 1. Journal of Immunology 2008 181 6 4072 4079 2-s2.0-56149122264
35. Gavanescu I., Benoist C., Mathis D., B cells are required for Aire-deficient mice to develop multi-organ autoinflammation: a therapeutic approach for APECED patients. Proceedings of the National Academy of Sciences of the United States of America 2008 105 35 13009 13014 2-s2.0-51349138423 10.1073/pnas.0806874105
36. Popler J., Alimohammadi M., Kämpe O., Autoimmune polyendocrine syndrome type 1: utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximab. Pediatric Pulmonology 2012 47 1 84 87
37. Winqvist O., Gustafsson J., Rorsman F., Karlsson F. A., Kampe O., Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. The Journal of Clinical Investigation 1993 92 5 2377 2385 2-s2.0-0027366956 (Pubitemid 23333545)
38. Perniola R., Falorni A., Clemente M. G., Forini F., Accogli E., Lobreglio G., Organ-specific and non-organ-specific autoantibodies in children and young adults with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). European Journal of Endocrinology 2000 143 4 497 503 2-s2.0-0033772333
39. Hedstrand H., Ekwall O., Olsson M. J., Landgren E., Kemp E. H., Weetman A. P., Perheentupa J., Husebye E., Gustafsson J., Betterle C., Kämpe O., Rorsman F., The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I. The Journal of Biological Chemistry 2001 276 38 35390 35395 2-s2.0-0035929680 10.1074/jbc.M102391200
40. Sköldberg F., Portela-Gomes G. M., Grimelius L., Nilsson G., Perheentupa J., Betterle C., Husebye E. S., Gustafsson J., Rönnblom A., Rorsman F., Kämpe O., Histidine decarboxylase, a pyridoxal phosphate-dependent enzyme, is an autoantigen of gastric enterochromaffin-like cells. The Journal of Clinical Endocrinology and Metabolism 2003 88 4 1445 1452 2-s2.0-17144464701 10.1210/jc.2002-021761 (Pubitemid 36623353)
41. Bensing S., Fetissov S. O., Mulder J., Perheentupa J., Gustafsson J., Husebye E. S., Oscarson M., Ekwall O., Crock P. A., Hökfelt T., Hulting A. L., Kämpe O., Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1. Proceedings of the National Academy of Sciences of the United States of America 2007 104 3 949 954 2-s2.0-33846528700 10.1073/pnas.0610070104 (Pubitemid 46154717)
42. Wolff A. S. B., Oftedal B. E. V., Kisand K., Ersvær E., Lima K., Husebye E. S., Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type i. Scandinavian Journal of Immunology 2010 71 6 459 467 2-s2.0-77952285422 10.1111/j.1365-3083.2010.02397.x
43. Proust-Lemoine E., Saugier-Véber P., Lefranc D., Dubucquoi S., Ryndak A., Buob D., Lalau J. D., Desailloud R., Weill J., Prin L., Lefebvre H., Wémeau J. L., Autoimmune polyendocrine syndrome type 1 in North-Western France: AIRE gene mutation specificities and severe forms needing immunosuppressive therapies. Hormone Research in Paediatrics 2010 74 4 275 284 2-s2.0-77958070140 10.1159/000297714
44. Meager A., Visvalingam K., Peterson P., Möll K., Murumägi A., Krohn K., Eskelin P., Perheentupa J., Husebye E., Kadota Y., Willcox N., Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Medicine 2006 3 7 e289 2-s2.0-33746423947 10.1371/journal.pmed.0030289 (Pubitemid 44125999)
45. Meloni A., Incani F., Corda D., Cao A., Rosatelli M. C., Role of PHD fingers and COOH-terminal 30 amino acids in AIRE transactivation activity. Molecular Immunology 2008 45 3 805 809 2-s2.0-34848917517 10.1016/j.molimm.2007. 06.156 (Pubitemid 47498571)
46. Oftedal B. E., Boe Wolff A. S., Bratland E., Kämpe O., Perheentupa J., Myhre A. G., Meager A., Purushothaman R., Ten S., Husebye E. S., Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I. Clinical Immunology 2008 129 1 163 169 2-s2.0-51249103389 10.1016/j.clim.2008.07.002
47. Anderson M. S., Venanzi E. S., Klein L., Chen Z., Berzins S. P., Turley S. J., Von Boehmer H., Bronson R., Dierich A., Benoist C., Mathis D., Projection of an immunological self shadow within the thymus by the aire protein. Science 2002 298 5597 1395 1401 2-s2.0-0037112047 10.1126/science.1075958 (Pubitemid 35346134)
48. Zheng X., Yin L., Liu Y., Zheng P., Expression of tissue-specific autoantigens in the hematopoietic cells leads to activation-induced cell death of autoreactive T cells in the secondary lymphoid organs. European Journal of Immunology 2004 34 11 3126 3134 2-s2.0-9244255248 10.1002/eji.200425177 (Pubitemid 39549391)
49. Hubert F. X., Kinkel S. A., Webster K. E., Cannon P., Crewther P. E., Proeitto A. I., Wu L., Heath W. R., Scott H. S., A specific anti-aire antibody reveals aire expression is restricted to medullary thymic epithelial cells and not expressed in periphery. Journal of Immunology 2008 180 6 3824 3832 2-s2.0-44849114330
50. Pöntynen N., Strengell M., Sillanpää N., Saharinen J., Ulmanen I., Julkunen I., Peltonen L., Critical immunological pathways are downregulated in APECED patient dendritic cells. Journal of Molecular Medicine 2008 86 10 1139 1152 2-s2.0-52549099420 10.1007/s00109-008-0374-7
51. Suzuki E., Kobayashi Y., Kawano O., Endo K., Haneda H., Yukiue H., Sasaki H., Yano M., Maeda M., Fujii Y., Expression of AIRE in thymocytes and peripheral lymphocytes. Autoimmunity 2008 41 2 133 139 2-s2.0-40649101249 10.1080/08916930701773941 (Pubitemid 351372295)
52. Poliani P. L., Kisand K., Marrella V., Ravanini M., Notarangelo L. D., Villa A., Peterson P., Facchetti F., Human peripheral lymphoid tissues contain autoimmune regulator-expressing dendritic cells. The American Journal of Pathology 2010 176 3 1104 1112 2-s2.0-77749279470 10.2353/ajpath.2010.090956
53. Gardner J. M., DeVoss J. J., Friedman R. S., Wong D. J., Tan Y. X., Zhou X., Johannes K. P., Su M. A., Chang H. Y., Krummel M. F., Anderson M. S., Deletional tolerance mediated by extrathymic aire-expressing cells. Science 2008 321 5890 843 847 2-s2.0-49449093723 10.1126/science.1159407
54. Aaltonen J., Bjorses P., Sandkuijl L., Perheentupa J., Peltonen L., An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21. Nature Genetics 1994 8 1 83 87 2-s2.0-0028064998 10.1038/ng0994-83 (Pubitemid 24274065)
55. Rosatelli M. C., Meloni A., Meloni A., Devoto M., Cao A., Scott H. S., Peterson P., Heino M., Krohn K. J. E., Nagamine K., Kudoh J., Shimizu N., Antonarakis S. E., A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Human Genetics 1998 103 4 428 434 2-s2.0-0031753977 10.1007/s004390050846 (Pubitemid 28542953)
56. Wolff A. S. B., Erichsen M. M., Meager A., Magitta N. F., Myhre A. G., Bollerslev J., Fougner K. J., Lima K., Knappskog P. M., Husebye E. S., Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. The Journal of Clinical Endocrinology and Metabolism 2007 92 2 595 603 2-s2.0-33846990524 10.1210/jc.2006-1873
57. Capalbo D., Mazza C., Giordano R., Molecular background and genotype-phenotype correlation in APECED patients from Campania and in their relatives. Journal of Endocrinological Investigation 2012 35 2 169 173
58. Cetani F., Barbesino G., Borsari S., Pardi E., Cianferotti L., Pinchera A., Marcocci C., A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis. The Journal of Clinical Endocrinology and Metabolism 2001 86 10 4747 4752 2-s2.0-0034749749 10.1210/jc.86.10.4747 (Pubitemid 33020515)
59. Podkrajšek K. T., Bratanič N., Kržišnik C., Battelino T., Autoimmune regulator-1 messenger ribonucleic acid analysis in a novel intronic mutation and two additional novel AIRE gene mutations in a cohort of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. The Journal of Clinical Endocrinology and Metabolism 2005 90 8 4930 4935 2-s2.0-23844507752 10.1210/jc.2005-0418 (Pubitemid 41159393)
60. Stolarski B., Pronicka E., Korniszewski L., Pollak A., Kostrzewa G., Rowiska E., Wodarski P., Skórka A., Gremida M., Krajewski P., Ploski R., Molecular background of polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome in a Polish population: novel AIRE mutations and an estimate of disease prevalence. Clinical Genetics 2006 70 4 348 354 2-s2.0-33748299062 10.1111/j.1399-0004.2006.00690.x (Pubitemid 44323402)
61. Scott H. S., Heino M., Peterson P., Mittaz L., Lalioti M. D., Betterle C., Cohen A., Seri M., Lerone M., Romeo G., Collin P., Salo M., Metcalfe R., Weetman A., Papasavvas M. P., Rossier C., Nagamine K., Kudoh J., Shimizu N., Krohn K. J. E., Antonarakis S. E., Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins. Molecular Endocrinology 1998 12 8 1112 1119 2-s2.0-0032230236 (Pubitemid 30659038)
62. Pearce S. H. S., Cheetham T., Imrie H., Vaidya B., Barnes N. D., Bilous R. W., Carr D., Meeran K., Shaw N. J., Smith C. S., Toft A. D., Williams G., Kendall-Taylor P., A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1. American Journal of Human Genetics 1998 63 6 1675 1684 2-s2.0-0032470812 10.1086/302145 (Pubitemid 30415730)
63. Dominguez M., Crushell E., Ilmarinen T., McGovern E., Collins S., Chang B., Fleming P., Irvine A. D., Brosnahan D., Ulmanen I., Murphy N., Costigan C., Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in the Irish population. Journal of Pediatric Endocrinology and Metabolism 2006 19 11 1343 1352 2-s2.0-33845706149 (Pubitemid 44963845)
64. Wang C. Y., Davoodi-Semiromi A., Huang W., Connor E., Shi J. D., She J. X., Characterization of mutations in patients with autoimmune polyglandular syndrome type 1 (APS1). Human Genetics 1998 103 6 681 685 2-s2.0-0032421986 10.1007/s004390050891 (Pubitemid 29020764)
65. Heino M., Scott H. S., Chen Q., Mutation analyses of North American APS-1 patients. Human Mutation 1999 13 1 69 74 (Pubitemid 29014378)
66. Björses P., Halonen M., Palvimo J. J., Kolmer M., Aaltonen J., Ellonen P., Perheentupa J., Ulmanen I., Peltonen L., Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasisectodermal dystrophy protein. American Journal of Human Genetics 2000 66 2 378 392 2-s2.0-0242536432 10.1086/302765 (Pubitemid 30468815)
67. Meloni A., Willcox N., Meager A., Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in sardinian patients. The Journal of Clinical Endocrinology and Metabolism 2012 97 4 1114 1124
68. Meloni A., Perniola R., Faà V., Corvaglia E., Cao A., Rosatelli M. C., Delineation of the molecular defects in the AIRE gene in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients from Southern Italy. The Journal of Clinical Endocrinology and Metabolism 2002 87 2 841 846 2-s2.0-0036171124 10.1210/jc.87.2.841 (Pubitemid 34158261)
69. Cervato S., Mariniello B., Lazzarotto F., Morlin L., Zanchetta R., Radetti G., De Luca F., Valenzise M., Giordano R., Rizzo D., Giordano C., Betterle C., Evaluation of the autoimmune regulator (AIRE) gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy-candidiasis- ectodermal-dystrophy (APECED) and in their relatives. Clinical Endocrinology 2009 70 3 421 428 2-s2.0-60349085274 10.1111/j.1365-2265.2008.03318.x
70. Giordano C., Modica R., Allotta M. L., Autoimmune Polyendocrinopathy- Candidiasis-Ectodermal-Dystrophy (APECED) in Sicily: confirmation that R203X is the peculiar AIRE gene mutation. Journal of Endocrinological Investigation 2012 35 4 384 388
71. Valenzise M., Wasniewska M., Mirabelli S., Identification of two novel mutations in the first Sicilian APECED patient with no R203X mutation in AIRE gene and review of Italian APECED genotypes. Gene 2012 499 2 343 346
72. Betterle C., Ghizzoni L., Cassio A., Autoimmune-Polyendocrinopathy- Candidiasis-Ectodermal- Dystrophy (APECED) in Calabria: clinical, immunological and genetic patterns. Journal of Endocrinological Investigation. In press
73. Ishii T., Suzuki Y., Ando N., Matsuo N., Ogata T., Novel mutations of the autoimmune regulator gene in two siblings with autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy. The Journal of Clinical Endocrinology and Metabolism 2000 85 8 2922 2926 2-s2.0-0034456540 10.1210/jc.85.8.2922 (Pubitemid 32269174)
74. Gylling M., Kääriäinen E., Väisänen R., Kerosuo L., Solin M. L., Halme L., Saari S., Halonen M., Kämpe O., Perheentupa J., Miettinen A., The hypoparathyroidism of autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy protective effect of male sex. The Journal of Clinical Endocrinology and Metabolism 2003 88 10 4602 4608 2-s2.0-10744230766 10.1210/jc.2003-030700 (Pubitemid 37357500)
75. Capalbo D., Fusco A., Aloj G., High intrafamilial variability in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: a case study. Journal of Endocrinological Investigation 2012 35 1 77 81
76. Halonen M., Eskelin P., Myhre A. G., Perheentupa J., Husebye E. S., Kämpe O., Rorsman F., Peltonen L., Ulmanen I., Partanen J., AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. The Journal of Clinical Endocrinology and Metabolism 2002 87 6 2568 2574 2-s2.0-18444378139 10.1210/jc.87.6.2568 (Pubitemid 34655315)
77. Gylling M., Tuomi T., Björses P., Kontiainen S., Partanen J., Christie M. R., Knip M., Perheentupa J., Miettinen A., β -cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. The Journal of Clinical Endocrinology and Metabolism 2000 85 12 4434 4440 2-s2.0-0034351867 10.1210/jc.85.12.4434 (Pubitemid 32157614)
78. Bluestone J. A., Mechanisms of tolerance. Immunological Reviews 2011 241 1 5 19 2-s2.0-79954551032 10.1111/j.1600-065X.2011.01019.x
79. DeFranco S., Bonissoni S., Cerutti F., Bona G., Bottarel F., Cadario F., Brusco A., Loffredo G., Rabbone I., Corrias A., Pignata C., Ramenghi U., Dianzani U., Defective function of Fas in patients with type 1 diabetes associated with other autoimmune diseases. Diabetes 2001 50 3 483 488 2-s2.0-0035123704 (Pubitemid 32195211)
80. Kekäläinen E., Tuovinen H., Joensuu J., Gylling M., Franssila R., Pöntynen N., Talvensaari K., Perheentupa J., Miettinen A., Arstila T. P., A defect of regulatory T cells in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Journal of Immunology 2007 178 2 1208 1215 2-s2.0-33846203837 (Pubitemid 46095195)
81. Hinchey J., Chaves C., Appignani B., Breen J., Pao L., Wang A., Pessin M. S., Lamy C., Mas J. L., Caplan L. R., A reversible posterior leukoencephalopathy syndrome. The New England Journal of Medicine 1996 334 8 494 500 2-s2.0-13344284635 10.1056/NEJM199602223340803 (Pubitemid 26067737)
82. Pignata C., Fiore M., de Filippo S., Cavalcanti M., Gaetaniello L., Scotese I., Apoptosis as a mechanism of peripheral blood mononuclear cell death after measles and varicella-zoster virus infections in children. Pediatric Research 1998 43 1 77 83 2-s2.0-0031941367 (Pubitemid 28069171)
83. Krohn K., Uibo R., Aavik E., Peterson P., Savilahti, Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17 α -hydroxylase. The Lancet 1992 339 8796 770 773 2-s2.0-0026552977 10.1016/0140-6736(92)91894-E
84. Reimand K., Perheentupa J., Link M., Krohn K., Peterson P., Uibo R., Testis-expressed protein TSGA10an auto-antigen in autoimmune polyendocrine syndrome type I. International Immunology 2008 20 1 39 44 2-s2.0-37549049748 10.1093/intimm/dxm118
85. Hedstrand H., Ekwall O., Haavik J., Landgren E., Betterle C., Perheentupa J., Gustafsson J., Husebye E., Rorsman F., Kämpe O., Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I. Biochemical and Biophysical Research Communications 2000 267 1 456 461 2-s2.0-0034614519 10.1006/bbrc.1999.1945 (Pubitemid 30072573)